美股A股
StockGist
Back
10-K2026-02-12· grok-4-1-fast-non-reasoning

NEU · NewMarket Corporation

0001282637-26-000005

SEC filing

Summary

NewMarket Corporation (NEU) reported strong financial performance for FY 2025 ending December 31, 2025, with net sales of $2.73B and net income of $418.7M. Gross profit reached $857.4M, reflecting robust margins in its operations. Operating profit stood at $543.7M after $181.6M in SG&A and $132.1M in R&D expenses. Income before tax was $560.6M, with tax expense of $141.8M leading to diluted EPS of $44. Balance sheet shows total assets of $3.49B, with current assets at $1.06B including $77.6M cash and $502.3M inventories. Total liabilities are $1.71B, including $883.4M long-term debt, yielding shareholders' equity of $1.78B. Cash from operations was a robust $569.0M, funding $291.1M in investing activities driven by $213.4M business acquisition and $77.6M capex. Financing activities used $279.1M, including $105.9M dividends and $77.2M stock repurchases. Ending cash was $68.7M after a $122K increase. The company reduced shares outstanding to 9,397,364 from 9,524,789, supporting EPS growth. Strong cash generation and strategic acquisition position NewMarket for sustained profitability amid ongoing investments.

Key takeaways

Full analysis

Performance Summary

NewMarket Corporation delivered solid FY 2025 results with net sales of $2.73B and gross profit of $857.4M. Operating profit was $543.7M after $181.6M SG&A and $132.1M R&D expenses. Net income reached $418.7M, or $44 diluted EPS, with shares outstanding at 9,397,364 versus 9,524,789 prior year. Total assets grew to $3.49B, supported by $1.06B current assets and $941.2M intangibles/goodwill. Liabilities totaled $1.71B, with shareholders' equity at $1.78B including $1.67B retained earnings. Cash from operations hit $569.0M, reflecting strong underlying profitability. No prior year figures disclosed for direct YoY comparison, but share reduction and $213.4M acquisition highlight capital allocation focus. (128 words)

Revenue Analysis

Net sales reported at $2.73B for FY 2025. No segment breakdown or geographic mix disclosed in the filing. Cost of goods sold was $1.87B. No specific growth drivers or YoY revenue changes provided in the extracted data. (42 words)

Margins & Profitability

Gross margin calculated at 31.4% ($857.4M / $2.73B). Operating margin at 19.9% ($543.7M / $2.73B). Interest expense net $39.7M offset by $56.5M other income, yielding pre-tax income of $560.6M. Effective tax rate approximately 25.3% ($141.8M / $560.6M). No prior year margins for comparison. Cost structure shows controlled SG&A at 6.6% of sales and R&D at 4.8%. (78 words)

Cash Flow & Balance Sheet

Operating cash flow $569.0M, driven by $418.7M net income, $122.4M depreciation, and working capital changes including -$32.8M inventories. Investing outflow $291.1M from $213.4M acquisition and $77.6M capex. Financing outflow $279.1M included $211.0M net borrowings, $105.9M dividends, $77.2M stock buybacks, and $50.0M debt principal payment. Ending cash $68.7M after $122K increase. Balance sheet liquid with $77.6M cash, $1.06B current assets vs. $419.3M current liabilities. Long-term debt $883.4M. (102 words)

Outlook

No management guidance, strategic priorities, or risk factors explicitly disclosed in the provided filing extract. Commitments noted in Note 21, but no forward-looking statements available. (32 words)